Autologous chondrocyte for severe hip osteoarthritis
This study aims to assess the safety and efficacy of intraarticular injection of autologous chondrocytes in patients with severe hip osteoarthritis.
Read More
All patients will have a cartilage biopsy taken from the knee cartilage non-weight bearing zone. Chodrocytes will be extracted and cultured for 4 weeks. No specific information regarding therapeutic cells was provided by the study sponsor.
Read More
Product Information for
Autologous chondrocyte for severe hip osteoarthritis